Retail News Breaks Archives
Drug chains: Research shows benefits of daily multivitamin
October 22nd, 2012
NEW YORK – Citing key findings of a major medical study on multivitamins, CVS/pharmacy and Walgreens are touting their stores and pharmacies as a destinations for consumers seeking dietary supplements and advice
The drug chains said Monday that according to new research by Brigham and Women's Hospital and Harvard University and published in the Journal of the American Medical Association, taking a daily multivitamin helped adult men reduce their risk of cancer.
In the 15-year study, which involved about 15,000 men over age 50, participants who took the Pfizer multivitamin Centrum Silver for an average of 11 years had an 8% lower risk of getting cancer, compared with those randomly chosen to get placebos.
The findings were presented last week at a meeting of the American Association for Cancer Research in Anaheim, Calif.
"Given this latest research, it's important that people talk to their physicians and pharmacists about taking a daily multivitamin if they aren't already," Troy Brennan, executive vice president and chief medical officer at CVS Caremark, said in a statement.
CVS/pharmacy noted that it offers a broad selection of popular and national-brand vitamins and supplements at its 7,400 stores, including special formulas for men, women and seniors.
CVS added that over the past few months, it has expanded its CVS Brand supplements to include new options such as gummy vitamins for adults, formulated to meet the specific nutritional needs of men and women, and new prenatal gummies. CVS Brand multivitamins typically cost 20% to 40% less than national-brand alternatives, the company said, but include the same active ingredients and follow the same testing guidelines and Food and Drug Administration regulations as national brands. All CVS Brand products also carry a 100% money-back guarantee.
Meanwhile, in light of the new research, Walgreens on Monday said its pharmacists are a go-to source for people seeking information about their vitamin options.
The study reported 2,669 cases of cancer diagnosed among the participants, including 1,290 of the 7,317 men who took the multivitamin and 1,379 of 7,324 taking the placebo. Cancer deaths were also lower among vitamin takers: 403 vs. 456, respectively.
"Our pharmacists are available to discuss vitamin options with individuals and counsel them about potential side effects that certain ingredients can have with select prescriptions," stated Kermit Crawford, president of pharmacy, health and wellness at Walgreens. "Our large selection of multivitamin products and expert advice from pharmacists can help customers make the right choice to get, stay and live well."